DC
Decheng Capital LLC
MENLO PARK CA · SEC CIK 0002010850
$731.75M2026Q2 reported value
14Positions
98.1%Top 10 weight · largest 61.9%
1 / 1New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
TNGX New+$625,200
2026Q2 top sells estimated at quarter-end value
RVMD Reduced-$7.65M
NAMS Reduced-$5.02M
KRYS Sold out-$1.89M
RCUS Reduced-$402,023
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| CGON | CG ONCOLOGY INC | $452.71M | 61.87% | 6,371,669 | 0 | 0.0% | — | Unchanged |
| NUVB | Nuvation Bio Inc. | $147.42M | 20.15% | 25,954,439 | 0 | 0.0% | — | Unchanged |
| — | AARDVARK THERAPEUTICS INC | $22.56M | 3.08% | 3,917,299 | 0 | 0.0% | — | Unchanged |
| ACRS | Aclaris Therapeutics, Inc. | $21.38M | 2.92% | 4,041,736 | 0 | 0.0% | — | Unchanged |
| UPB | Upstream Bio Inc. | $18.86M | 2.58% | 2,724,868 | 0 | 0.0% | — | Unchanged |
| RCUS | Arcus Biosciences, Inc | $14.33M | 1.96% | 464,779 | -13,040 | -2.7% | -$402,023 | Reduced |
| EQ | Equillium Inc. | $14.23M | 1.94% | 4,447,308 | 0 | 0.0% | — | Unchanged |
| RVMD | REVOLUTION MEDICINES INC(NSM) | $9.86M | 1.35% | 52,667 | -40,833 | -43.7% | -$7.65M | Reduced |
| — | Lyell Immunopharma, Inc. | $9.72M | 1.33% | 692,050 | 0 | 0.0% | — | Unchanged |
| — | BeyondSpring Inc. | $6.65M | 0.91% | 3,800,702 | 0 | 0.0% | — | Unchanged |
| ZNTL | Zentalis Pharmaceuticals Inc. | $6.42M | 0.88% | 1,323,327 | 0 | 0.0% | — | Unchanged |
| NAMS | NEWAMSTERDAM PHARMA CO NV | $5.99M | 0.82% | 176,887 | -148,170 | -45.6% | -$5.02M | Reduced |
| — | Pyxis Oncology, Inc (formerly Apexigen) | $983,698 | 0.13% | 326,810 | 0 | 0.0% | — | Unchanged |
| TNGX | TANGO THERAPEUTICS INC | $625,200 | 0.09% | 20,000 | 20,000 | — | $625,200 | New |
| KRYS | KRYSTAL BIOTECH INC | $0 | 0.00% | 0 | -7,300 | -100.0% | -$1.89M | Sold out |